Breaking News Instant updates and real-time market news.

MMSI

Merit Medical

$23.90

0.3 (1.27%)

09:28
10/19/16
10/19
09:28
10/19/16
09:28

Merit Medical completes enrollment in EVOLVE study

Merit Medical Systems announced that it has completed enrollment in its EVOLVE study. The study is investigating whether the unique valve in the EndoMAXX EVT stent can facilitate swallowing by treating the esophageal stricture while also limiting reflux.

  • 26

    Oct

  • 17

    Nov

  • 29

    Nov

MMSI Merit Medical
$23.90

0.3 (1.27%)

10/26/15
10/26/15
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AMC Networks (AMCX) upgraded to Buy from Outperform at CLSA... AMRI (AMRI) upgraded to Overweight from Equal-Weight at First Analysis... Applied Materials (AMAT) upgraded to Buy from Neutral at Nomura... Arctic Cat (ACAT) upgraded on valuation at BMO Capital... Beacon Roofing (BECN) upgraded to Overweight from Neutral at JPMorgan... Commvault (CVLT) upgraded to Overweight from Neutral at Piper Jaffray... Costco (COST) upgraded to Buy from Neutral at UBS... DISH (DISH) upgraded to Neutral from Sell at MoffettNathanson... Dime Community (DCOM) upgraded to Overweight from Neutral at Piper Jaffray... EQT Corporation (EQT) upgraded to Overweight from Equal Weight at Morgan Stanley... Enphase Energy (ENPH) upgraded to Neutral from Sell at Goldman... Goldman Sachs (GS) upgraded to Overweight from Equal Weight at Morgan Stanley... HeartWare (HTWR) upgraded to Buy from Neutral at BTIG... Highwoods Properties (HIW) upgraded to Buy from Hold at Jefferies... Hologic (HOLX) upgraded to Buy from Neutral at BTIG... HomeAway (AWAY) upgraded to Outperform from Market Perform at Cowen... Interxion (INXN) upgraded to Buy from Hold at Evercore ISI... MarketAxess (MKTX) upgraded to Outperform from Market Perform at Raymond James... Merit Medical (MMSI) upgraded to Outperform from Market Perform at Barrington... Murphy USA (MUSA) upgraded to Outperform from Market Perform at Wells Fargo... Pandora (P) upgraded to Outperform from Neutral at Macquarie... PayPal (PYPL) upgraded to Conviction Buy from Buy at Goldman... Pebblebrook Hotel (PEB) upgraded to Buy from Hold at Evercore ISI... Post Holdings (POST) upgraded to Buy from Hold at Stifel... Raymond James (RJF) upgraded to Buy from Neutral at Citi... Santander Mexico (BSMX) upgraded to Neutral from Sell at Citi... U.S. Bancorp (USB) upgraded to Overweight at Stephens... VF Corp. (VFC) upgraded to Overweight from Neutral at Piper Jaffray... Waddell & Reed (WDR) upgraded to Neutral from Sell at Citi... Whirlpool (WHR) upgraded to Strong Buy from Market Perform at Raymond James... Xilinx (XLNX) upgraded to Conviction Buy from Buy at Goldman... ZELTIQ (ZLTQ) upgraded to Conviction Buy from Buy at Goldman.
07/19/16
ADAM
07/19/16
INITIATION
Target $27
ADAM
Buy
Merit Medical initiated with a Buy at Canaccord
Canaccord initiated Merit Medical with a Buy rating, citing its expectations for accelerating revenue growth and eventual higher multiple expansion. Canaccord has a $27 price target on Merit Medical shares.
07/28/16
BRRR
07/28/16
DOWNGRADE
BRRR
Market Perform
Merit Medical downgraded to Market Perform from Outperform at Barrington
07/28/16
BRRR
07/28/16
DOWNGRADE
BRRR
Market Perform
Merit Medical downgraded to Market Perform at Barrington
As previously reported, Barrington analyst Michael Petusky downgraded Merit Medical to Market Perform from Outperform, citing his view that near-term price appreciation will be limited following the stock's 50% rally from its February lows.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.